ImmunoGen Inc. (IMGN)
NASDAQ: IMGN
· Real-Time Price · USD
31.23
0.00 (0.00%)
At close: Feb 09, 2024, 9:58 PM
ImmunoGen Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 287.61M | 189.56M | 120.57M | 108.78M | 95.61M | 89.44M | 92.23M | 69.86M | 127.66M | 136.64M | 134.72M |
Cost of Revenue | 3.87M | 2.13M | 1.23M | 600K | 34.84M | 34.41M | 34.41M | 68.83M | 73.99M | 98.68M | 121.6M |
Gross Profit | 283.75M | 187.43M | 119.35M | 108.18M | 60.77M | 55.03M | 57.81M | 1.03M | 53.67M | 37.97M | 13.12M |
Operating Income | -80.19M | -183.57M | -240.43M | -220.89M | -195.89M | -152.69M | -119.01M | -125.07M | -54M | -36.49M | -27.49M |
Interest Income | 11.08M | 7.77M | 6.46M | 4.29M | 2.13M | 590K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -72.59M | -179.93M | -238.58M | -221.71M | -201.09M | -160.68M | -129.4M | -139.3M | -70.74M | -55.78M | -49.34M |
Net Income | -73.07M | -181.9M | -240.64M | -225.52M | -203.68M | -162.94M | -130.69M | -139.3M | -70.74M | -55.78M | -49.34M |
Selling & General & Admin | 156.18M | 152.06M | 139.5M | 116.13M | 87.64M | 64.32M | 50.25M | 43.81M | 39.97M | 39.91M | 39.95M |
Research & Development | 207.75M | 219.36M | 220.71M | 213.37M | 203.85M | 177.82M | 160.99M | 151.12M | 141.73M | 133.26M | 121.6M |
Other Expenses | -172K | -8K | 110K | 12K | -455K | -809K | -711K | -1.08M | -41K | 324K | 284K |
Operating Expenses | 363.93M | 371.42M | 360.2M | 329.5M | 291.5M | 242.13M | 211.24M | 194.93M | 181.7M | 173.17M | 161.54M |
Interest Expense | 3.96M | 3.77M | 3.77M | 4.17M | 5.34M | 7.23M | 9.73M | 13.15M | 16.7M | 19.62M | 22.14M |
Selling & Marketing Expenses | 18.27M | 18.27M | 18.27M | 18.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 367.8M | 373.13M | 361.01M | 329.68M | 291.5M | 242.13M | 211.24M | 194.93M | 181.7M | 173.17M | 161.54M |
Income Tax Expense | 481K | 1.97M | 2.06M | 3.81M | 2.59M | 2.26M | 1.29M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 273.34M | 263.45M | 258.85M | 253.26M | 250.82M | 253.34M | 253.26M | 210.86M | 204.84M | 199.89M | 198.84M |
Shares Outstanding (Diluted) | 287.59M | 263.45M | 258.85M | 254.41M | 253.51M | 253.34M | 253.26M | 215.83M | 204.84M | 199.89M | 198.84M |
EPS (Basic) | -0.31 | -0.72 | -0.95 | -0.89 | -0.83 | -0.7 | -0.6 | -0.67 | -0.33 | -0.28 | -0.27 |
EPS (Diluted) | -0.31 | -0.72 | -0.95 | -0.89 | -0.83 | -0.7 | -0.6 | -0.67 | -0.34 | -0.29 | -0.28 |
EBITDA | -68.64M | -177.28M | -235.93M | -218.24M | -196.44M | -153.03M | -119.25M | -126.15M | -54.08M | -35.68M | -26.02M |
EBIT | -68.64M | -176.16M | -234.81M | -217.55M | -195.75M | -153.45M | -119.67M | -126.15M | -54M | -36.12M | -27.15M |
Depreciation & Amortization | 5.82M | 4.83M | 4.51M | 2.65M | 373K | 1.41M | 1.84M | 2.02M | 2.09M | 2.15M | 2.12M |